VFY.AX · VITRAFY LIFE SCIENCES LIMITED
Australia · RS rating 86 · As of 2026-10-14
| Price | 3.04 AUD |
|---|---|
| 1-day change | -1.3% |
| RS rating (overall / 1M / 3M / 12M) | 86 / 31 / 75 / 97 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 38 / 59 / 30 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +34.3% |
| Market cap (USD) | $165.0M |